The milestones in xenotransplantation – cross-species transplants – rely on cutting-edge biotechnologies, including the use ...

The discovery by the UK Health Security Agency (UKHSA) raises the possibility that viral diseases that are known to be ...

Novartis has paused eight clinical trials of its experimental CAR-T therapy rapcabtagene autoleucel (rap-cel or YTB323) after ...

Ionis' antisense therapy Zanvastro has been approved by the FDA for Alexander disease (AxD), throwing a lifeline to people ...

Editor's Note: pharmaphorum is an editorially independent publication owned by EVERSANA.

Novartis' oral BTK inhibitor remibrutinib has shown efficacy in a pair of phase 3 trials in relapsing multiple sclerosis (RMS ...

Interim data from the 393-patient phase 3 CERVINO trial of etentamig (ABBV-383), a bispecific CD3 and BCMA-directed TCE, ...

The US FDA issued similar warning letters to five different online peptide vendors on 24th August, giving the companies 15 ...

The FDA issued approvals for Pfizer and Moderna's 2026 COVID-19 vaccines on Thursday, but is recommending them for the same ...

PMV Pharma is preparing to file for approval of its oral p53 protein reactivator drug rezatopopt in the first quarter of 2027 ...

GSK is planning to start a phase 3 trial of the new vaccine later this month, saying it will be the first late-stage trial of ...

The new acquisition is Lilly's ninth since the start of the year, coming just a few weeks after it agreed to buy psychedelic ...